Ian M. Silverman
Impact in
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- RNA Research and Splicing 13
- RNA modifications and cancer 12
- Fibroblast Growth Factor Research 10
- RNA and protein synthesis mechanisms 7
- DNA Repair Mechanisms 4
-
- Cancer Genomics and Diagnostics 9
- Cancer-related molecular mechanisms research 5
- Co-authors
- Brian D. Gregory (15 shared papers)Luis Féliz (7 shared papers)Sager J. Gosai (5 shared papers)Timothy C. Burn (6 shared papers)Robert Newton (4 shared papers)Fan Li (2 shared papers)Hui‐Ling Zhen (3 shared papers)Li‐San Wang (3 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (3 papers)ESMO Open (2 papers)Genome biology (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Ian M. Silverman
38 papers receiving 1.5k citations
Ian M. Silverman's Hit Papers
Peers
Comparison fields: 5 of 85
- Geriatrics and Gerontology 161
- Cancer Research 248
- Physiology 77
- Molecular Biology 927
- Oncology 252
Countries citing papers authored by Ian M. Silverman
This map shows the geographic impact of Ian M. Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian M. Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian M. Silverman more than expected).
Fields of papers citing papers by Ian M. Silverman
This network shows the impact of papers produced by Ian M. Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian M. Silverman. The network helps show where Ian M. Silverman may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian M. Silverman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 277 | |
| 2 | Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib Hit paper breakdown → | 2020 | 202 |
| 3 | 2022 | 132 | |
| 4 | 2013 | 113 | |
| 5 | 2014 | 88 | |
| 6 | 2014 | 69 | |
| 7 | 2014 | 61 | |
| 8 | 2019 | 57 | |
| 9 | 2015 | 56 | |
| 10 | 2013 | 47 | |
| 11 | 2015 | 46 | |
| 12 | 2013 | 41 | |
| 13 | 2015 | 36 | |
| 14 | 2017 | 33 | |
| 15 | 2019 | 32 | |
| 16 | 2016 | 27 | |
| 17 | 2022 | 26 | |
| 18 | 2016 | 18 | |
| 19 | 2019 | 13 | |
| 20 | 2016 | 12 |
About Ian M. Silverman
Ian M. Silverman is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 42 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA Research and Splicing (13 papers), RNA modifications and cancer (12 papers), Fibroblast Growth Factor Research (10 papers), Cancer Genomics and Diagnostics (9 papers), RNA and protein synthesis mechanisms (7 papers), Cancer-related molecular mechanisms research (5 papers), DNA Repair Mechanisms (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Geriatrics and Gerontology (161 citations), Cancer Research (248 citations), Physiology (77 citations), Molecular Biology (927 citations) and Oncology (252 citations). Ian M. Silverman has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Brian D. Gregory, Luis Féliz, Sager J. Gosai, Timothy C. Burn, Robert Newton, Fan Li, Hui‐Ling Zhen, Li‐San Wang, Davide Melisi and Antoine Hollebecque. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Molecular Cancer Therapeutics, ESMO Open and Genome biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.